Mosaic ImmunoEngineering (OTCMKTS:CPMV) Stock Price Down 11.1% – Time to Sell?

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) was down 11.1% during mid-day trading on Wednesday . The company traded as low as $0.31 and last traded at $0.3110. Approximately 3,491 shares traded hands during mid-day trading, an increase of 374% from the average daily volume of 737 shares. The stock had previously closed at $0.35.

Mosaic ImmunoEngineering Price Performance

The firm has a market capitalization of $2.25 million, a PE ratio of -3.46 and a beta of -0.84. The firm has a fifty day moving average price of $0.56 and a 200 day moving average price of $0.54.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last posted its quarterly earnings data on Wednesday, November 19th. The company reported ($0.02) earnings per share (EPS) for the quarter.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.

Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.